# FDA recall D0384-2015

> **AnazaoHealth Corporation** · Class II · drug recall initiated 2015-01-26.

## Product

Compounded Plaquex, intravenous injection, 50 ML vial.   Each ml contains: Phosphatidyl Choline 50 mg, Sodium Deoxycholate 25 mg, Benzyl Alcohol 0.9%, Ethanol (95%) 2.4 mg di Alpha Tocopheryl Acetate 0.2 mg in Sterile Water for injection.

## Reason for recall

Good Manufacturing Practices Deviations: The product has an active pharmaceutical ingredient from an unapproved source.

## Distribution

Nationwide

## Key facts

- **Recall number:** D0384-2015
- **Recalling firm:** AnazaoHealth Corporation
- **Classification:** Class II
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2015-01-26
- **Report date:** 2015-02-18
- **Termination date:** 2015-02-09

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Las Vegas, NV, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D0384-2015

## Citation

> AI Analytics. FDA recall D0384-2015. Retrieved 2026-05-26 from https://api.ai-analytics.org/recall/D0384-2015. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*
